[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
3SBio Inc.
3SBio Inc. announces significant progress in its oncology pipeline and a major partnership with Pfizer, driving positive sentiment and market interest.
About 3SBio Inc.
3SBio Inc. is a biotechnology company focused on developing innovative therapies, particularly in oncology.
Price: $
Price 24-Hour Time-Series Raw Data
The price is likely to increase due to positive news regarding partnerships with Pfizer and progress in the oncology pipeline, as indicated by the supportive social posts.
1-Year High: $XXXXX on 2025-09-09
1-Year Low: $XXXX on 2025-01-10
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
3SBio Inc. is currently AltRank #694 based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2025-01-28
1-Year Low: XXX on 2025-11-17
Galaxy Score: XX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XXX on 2025-03-24
1-Year Low: XX on 2025-02-15
Engagements: XX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
X Week: XXX -XX%
X Month: XXXXXX +25%
X Months: XXXXXXX -XX%
X Year: XXXXXXX +89,002%
1-Year High: XXXXXXX on 2025-05-20
1-Year Low: X on 2025-02-08
Engagements by network (24h): Reddit: XX X: XX
Mentions: X (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XX%
X Month: XX -XX%
X Months: XXX +12%
X Year: XXX +4,085%
1-Year High: XXX on 2025-05-20
1-Year Low: X on 2025-02-08
Mentions by network (24h): Reddit: XX X: XX
Creators: X (24h)
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning 3SBio Inc. in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XX -XX%
X Months: XXX +2.90%
X Year: XXX +5,100%
1-Year High: XXX on 2025-05-20
1-Year Low: X on 2025-02-08
The most influential creators that mention 3SBio Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @ForbesAsia | X | XXXXXX | X | X |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XXX% no change
X Months: XXX% +31%
X Year: XXX% no change
1-Year High: XXX% on 2025-02-07
1-Year Low: XX% on 2025-10-18
Most Supportive Themes:
- Partnership with Pfizer and Oncology Pipeline Progress: (45%) Positive news regarding partnerships with Pfizer and progress in the oncology pipeline are driving interest.
- Positive Clinical Results for SA102 CAR-T Therapy: (30%) Positive clinical results for SA102 CAR-T therapy are boosting interest in the company's stock.
- Chinese Biotech Market and Momentum: (25%) 3SBio is highlighted as a key player in the Chinese biotech market, with discussions around momentum and growth.
Most Critical Themes:
- Criticism of Pfizer: (5%) Some posts express negative sentiment towards Pfizer.
Market Cap: $undefined
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXX on 2025-04-01
1-Year Low: $XXXXXXXXXXXXXX on 2025-01-10
Top 3SBio Inc. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"After grabbing the spotlight this year with a big licensing deal Chinese drug developer 3SBio is now raising extra funds for R&D and shedding a non-core subsidiary"
X Link @WorksBamboo 2025-12-11T06:30Z XXX followers, XX engagements
"Partnership follows tie-up with China's 3SBio earlier this year. Read:"
X Link @ForbesAsia 2025-12-10T13:00Z 31.7K followers, XX engagements
"3SBio's valuation logic shifting away from Mandi focusing on innovative drug R&D for future growth and potential to surpass peers with good clinical data. 3SBio has big upside based on Placing price"
X Link @crisswang276 2025-12-04T01:00Z XX followers, XX engagements
"CB Daily Brief 21/11/25 $0727.HK: rights issue $1530.HK: proposed carve-out of consumer pharma co $WJL.AX: competing bid by BGH at A$0.91 $PPH.L: strategic review / formal sale process $NEXT25.MX: carve-out from $FUNO11.MX $WTM: tender offer for X% at $1850-2050"
X Link @DealintCB 2025-11-21T14:37Z 2168 followers, XXX engagements